Mutations in the bone morphogenetic protein receptor type II gene (BMPR2) affect not only the risk of developing pulmonary arterial hypertension (PAH) but also the severity and outcomes of the disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results